CS
CDNA icon

Credit Suisse’s CareDx CDNA Stock Holding History

Credit Suisse’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-47,099
Closed -$330K – 3073
2023
Q3 		$330K Sell
47,099
-16,053
-25% -$148K ﹤0.01% 2897
2023
Q2 		$537K Sell
63,152
-419,629
-87% -$3.5M ﹤0.01% 2741
2023
Q1 		$4.41M Sell
482,781
-749,251
-61% -$9.58M ﹤0.01% 1406
2022
Q4 		$14.1M Buy
1,232,032
+199
+0% +$2.95K 0.01% 786
2022
Q3 		$21M Buy
1,231,833
+501
+0% +$10.8K 0.02% 647
2022
Q2 		$26.4M Sell
1,231,332
-14,760
-1% -$409K 0.03% 591
2022
Q1 		$46.1M Buy
1,246,092
+6,576
+0.5% +$256K 0.04% 470
2021
Q4 		$56.4M Buy
1,239,516
+145,566
+13% +$7.6M 0.03% 577
2021
Q3 		$69.3M Buy
1,093,950
+19,067
+2% +$1.45M 0.04% 503
2021
Q2 		$98.4M Sell
1,074,883
-92,375
-8% -$7.34M 0.05% 387
2021
Q1 		$79.5M Buy
1,167,258
+89,732
+8% +$6.97M 0.04% 505
2020
Q4 		$78.1M Sell
1,077,526
-268,003
-20% -$15.5M 0.04% 512
2020
Q3 		$51M Sell
1,345,529
-12,219
-0.9% -$413K 0.03% 599
2020
Q2 		$48.1M Sell
1,357,748
-7,798
-0.6% -$222K 0.03% 554
2020
Q1 		$29.8M Sell
1,365,546
-11,037
-0.8% -$247K 0.03% 647
2019
Q4 		$29.7M Buy
1,376,583
+75,426
+6% +$1.73M 0.02% 808
2019
Q3 		$29.4M Buy
1,301,157
+162,642
+14% +$4.5M 0.02% 704
2019
Q2 		$41M Buy
1,138,515
+134,908
+13% +$4.32M 0.04% 538
2019
Q1 		$31.6M Sell
1,003,607
-283,360
-22% -$8.26M 0.03% 612
2018
Q4 		$32.4M Buy
1,286,967
+43,915
+4% +$1.13M 0.03% 545
2018
Q3 		$35.9M Buy
1,243,052
+12,260
+1% +$229K 0.03% 562
2018
Q2 		$15.1M Buy
+1,230,792
New +$14.1M 0.01% 997
2015
Q3 		– Sell
-642,299
Closed -$4.17M – 4282
2015
Q2 		$4.17M Sell
642,299
-78
-0% -$424 ﹤0.01% 1901
2015
Q1 		$3.56M Buy
642,377
+278
+0% +$1.83K ﹤0.01% 1941
2014
Q4 		$4.66M Hold
642,099
– – ﹤0.01% 1816
2014
Q3 		$4.5M Buy
+642,099
New +$6.17M ﹤0.01% 1837

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Credit Suisse's CDNA Position: Q4 2023 in Review

Credit Suisse sold out of CareDx (CDNA) in Q4 2023, closing a stake of 47,099 shares — an estimated $330K sold.

Credit Suisse first reported a position in CDNA in Q3 2014 and held it in 26 quarters. The position peaked at $98.4M in Q2 2021. 147 funds tracked by Wall St. Rank hold CDNA as of Q4 2023.

  • Credit Suisse reported no remaining CareDx position as of Q4 2023 after selling out during the quarter.
  • Credit Suisse sold 47,099 CareDx shares in Q4 2023, an estimated $330K.
  • Credit Suisse first reported a position in CareDx in Q3 2014 and held it in 26 quarters.
  • Credit Suisse's CareDx position peaked at $98.4M in Q2 2021.
  • 147 funds tracked by Wall St. Rank held CareDx as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.